Publications 2023 
 Original Paper
 
 
A rose flavor compound activating the NRF2 pathway in dendritic cells ameliorates contact hypersensitivity in mice 
Kodama N, Okada H, Hachisu M, Ando M, Ito N, Nagata K, Katagiri M, Yasuda Y, Hiroki I, Yashiro T, Ichihara G, Yamamoto M, Nishiyama C.
Front Nutr.    10, 1081263  (2023)
 
Multiomics and artificial intelligence enabled peripheral blood-based prediction of amnestic mild cognitive impairment 
Tatara Y, Yamazaki H, Katsuoka F, Chiba M, Saigusa D, Kasai S, Nakamura T, Inoue J, Aoki Y, Shoji M, Motoike IN, Tamada Y, Hashizume K, Shoji M, Kinoshita K, Murashita K, Nakaji S, Yamamoto M, Itoh K.
Curr Res Transl Med.   71, 103367  (2023)
 
Changes in glial cells and neurotrophic factors due to rotenone-induced oxidative stress in Nrf2 knockout mice 
Inoue-Yanagimachi M, Himori N, Uchida K, Tawarayama H, Sato K, Yamamoto M, Namekata K, Harada T, Nakazawa T.
Exp Eye Res.   226, 109314  (2023)
 
Selective Elimination of NRF2-Activated Cells by Competition With Neighboring Cells in the Esophageal Epithelium 
Hirose W, Horiuchi M, Li D, Motoike IN, Zhang L, Nishi H, Taniyama Y, Kamei T, Suzuki M, Kinoshita K, Katsuoka F, Taguchi K, Yamamoto M.
Cell Mol Gastroenterol Hepatol.    15, 153-178  (2023)
大学院生の廣瀬さんの論文です
 
Sulforaphane decreases serum selenoprotein P levels through enhancement of lysosomal degradation independent of Nrf2 
Ye X, Toyama T, Taguchi K, Arisawa K, Kaneko T, Tsutsumi R, Yamamoto M, Saito Y.
Commun Biol.   6(1), 1060  (2023)
 
Immunoediting of KEAP1-NRF2 mutant tumours is required to circumvent NRF2-mediated immune surveillance 
Baird L, Yamamoto M.
Redox Biol.   67, 102904  (2023)
Liam Baird助教の論文です
 
Immunohistochemical expression of NRF2 is correlated with the magnitude of inflammation and fibrosis in chronic liver disease 
To K, Okada K, Watahiki T, Suzuki H, Tsuchiya K, Tokushige K, Yamamoto M, Ariizumi SI, Shoda J.
Cancer Med.    12(19), 19423-19437.  (2023)
 
Nrf2 alleviates spaceflight-induced immunosuppression and thrombotic microangiopathy in mice 
Shimizu R, Hirano I, Hasegawa A, Suzuki M, Otsuki A, Taguchi K, Katsuoka F, Uruno A, Suzuki N, Yumoto A, Okada R, Shirakawa M, Shiba D, Takahashi S, Suzuki T, Yamamoto M.
Commun Biol.    6(1), 875  (2023)
宇宙マウス血液の解析(清水律子教授との共同研究)
 
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes 
Kowalik MA, Taguchi K, Serra M, Caddeo A, Puliga E, Bacci M, Koshiba S, Inoue J, Hishinuma E, Morandi A, Giordano S, Perra A, Yamamoto M, Columbano A.
Hepatology.   79(4), 829-843  (2023)
 
A NRF2-induced secretory phenotype activates immune surveillance to remove irreparably damaged cells 
Baird L, Taguchi K, Zhang A, Takahashi Y, Suzuki T, Kensler TW, Yamamoto M.
Redox Biol.   66, 102845  (2023)
Liam Baird助教のNISP論文
 
Nrf2 activation improves experimental rheumatoid arthritis 
Zhang A, Suzuki T, Adachi S, Yoshida E, Sakaguchi S, Yamamoto M.
Free Radic Biol Med.   207, 279-295  (2023)
博士課程Zhang Anqiさんの論文
 
Role of Nrf2 in 1,2-dichloropropane-induced cell proliferation and DNA damage in the mouse liver 
Kimura Y, Ekuban FA, Zong C, Sugie S, Zhang X, Itoh K, Yamamoto M, Ichihara S, Ohsako S, Ichihara G.
Toxicol Sci.   195(1), 28-41  (2023)
 
Insights into the Regulation of GFR by the Keap1-Nrf2 Pathway 
Kidokoro K, Kadoya H, Cherney DZI, Kondo M, Wada Y, Umeno R, Kishi S, Nagasu H, Nagai K, Suzuki T, Sasaki T, Yamamoto M, Kanwar YS, Kashihara N.
Kidney360.   4(10), 1454-1466  (2023)
 
A Point Mutation at C151 of Keap1 of Mice Abrogates NRF2 Signaling, Cytoprotection in Vitro, and Hepatoprotection in Vivo by Bardoxolone Methyl (CDDO-Me) 
Gatbonton-Schwager T, Yagishita Y, Joshi T, Wakabayashi N, Srinivasan H, Suzuki T, Yamamoto M, Kensler TW.
Mol Pharmacol.   104(2), 51-61  (2023)
 
Desmoglein 2 Functions as a Receptor for Fatty Acid Binding Protein 4 in Breast Cancer Epithelial Cells 
Chen D, Wirth KM, Kizy S, Muretta JM, Markowski TW, Yong P, Sheka A, Abdelwahab H, Hertzel AV, Ikramuddin S, Yamamoto M, Bernlohr DA.
Mol Cancer Res.   21(8), 836-848  (2023)
 
Toxicity manifestations and sex differences due to MARTA olanzapine 
Hattori-Usami N, Kaizaki-Mitsumoto A, Ashino T, Yamamoto M, Numazawa S.
J Toxicol Sci.   48(4), 191-202  (2023)
 
Changes in glial cells and neurotrophic factors due to rotenone-induced oxidative stress in Nrf2 knockout mice 
Inoue-Yanagimachi M, Himori N, Uchida K, Tawarayama H, Sato K, Yamamoto M, Namekata K, Harada T, Nakazawa T.
Exp Eye Res.    226, 109314.  (2023)

 Review
 
 
The KEAP1-NRF2 System and Neurodegenerative Diseases. 
Uruno A, Yamamoto M.
Antioxid Redox Signal.     (2023)
宇留野准教授のKEAP1-NRF2系と神経変性疾患の総説です
 
Molecular Basis of the KEAP1-NRF2 Signaling Pathway. 
Suzuki T, Takahashi J, Yamamoto M.
Mol Cells.   46, 133-141  (2023)
鈴木隆史准教授のKEAP1-NRF2系の分子機構の総説です

 日本語著書 (Publications in Japanese)
 

[編集]
CGI-design